Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1994 Jan;78(1):1–2. doi: 10.1136/bjo.78.1.1

The treatment of chronic uveitic macular oedema.

A D Dick
PMCID: PMC504679  PMID: 8110690

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Caspi R. R., Roberge F. G., McAllister C. G., el-Saied M., Kuwabara T., Gery I., Hanna E., Nussenblatt R. B. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol. 1986 Feb 1;136(3):928–933. [PubMed] [Google Scholar]
  2. Charteris D. G., Barton K., McCartney A. C., Lightman S. L. CD4+ lymphocyte involvement in ocular Behçet's disease. Autoimmunity. 1992;12(3):201–206. doi: 10.3109/08916939209148460. [DOI] [PubMed] [Google Scholar]
  3. Cox S. N., Hay E., Bird A. C. Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol. 1988 Sep;106(9):1190–1195. doi: 10.1001/archopht.1988.01060140350030. [DOI] [PubMed] [Google Scholar]
  4. Diamond J. G., Kaplan H. J. Lensectomy and vitrectomy for complicated cataract secondary to uveitis. Arch Ophthalmol. 1978 Oct;96(10):1798–1804. doi: 10.1001/archopht.1978.03910060310002. [DOI] [PubMed] [Google Scholar]
  5. Dua H. S., Lee R. H., Lolley R. N., Barrett J. A., Abrams M., Forrester J. V., Donoso L. A. Induction of experimental autoimmune uveitis by the retinal photoreceptor cell protein, phosducin. Curr Eye Res. 1992;11 (Suppl):107–111. doi: 10.3109/02713689208999519. [DOI] [PubMed] [Google Scholar]
  6. Dua H. S., McKinnon A., McMenamin P. G., Forrester J. V. Ultrastructural pathology of the 'barrier sites' in experimental autoimmune uveitis and experimental autoimmune pinealitis. Br J Ophthalmol. 1991 Jul;75(7):391–397. doi: 10.1136/bjo.75.7.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Flach A. J. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol. 1992 Jan-Feb;36(4):259–284. doi: 10.1016/0039-6257(92)90095-b. [DOI] [PubMed] [Google Scholar]
  8. Flach A. J., Stegman R. C., Graham J., Kruger L. P. Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology. 1990 Oct;97(10):1253–1258. doi: 10.1016/s0161-6420(90)32423-5. [DOI] [PubMed] [Google Scholar]
  9. Forrester J. V. Endogenous posterior uveitis. Br J Ophthalmol. 1990 Oct;74(10):620–623. doi: 10.1136/bjo.74.10.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Forrester J. V., Liversidge J., Dua H. S. Regulation of the local immune response by retinal cells. Curr Eye Res. 1990;9 (Suppl):183–191. doi: 10.3109/02713689008999440. [DOI] [PubMed] [Google Scholar]
  11. Greenwood J. The blood-retinal barrier in experimental autoimmune uveoretinitis (EAU): a review. Curr Eye Res. 1992;11 (Suppl):25–32. doi: 10.3109/02713689208999508. [DOI] [PubMed] [Google Scholar]
  12. Lightman S. L., Caspers-Velu L. E., Hirose S., Nussenblatt R. B., Palestine A. G. Angiography with fluorescein-labeled dextrans in a primate model of uveitis. Arch Ophthalmol. 1987 Jun;105(6):844–848. doi: 10.1001/archopht.1987.01060060130048. [DOI] [PubMed] [Google Scholar]
  13. Lightman S., Towler H. Immunopathology and altered immunity in posterior uveitis in man: a review. Curr Eye Res. 1992;11 (Suppl):11–15. doi: 10.3109/02713689208999506. [DOI] [PubMed] [Google Scholar]
  14. Lightman S. Use of steroids and immunosuppressive drugs in the management of posterior uveitis. Eye (Lond) 1991;5(Pt 3):294–298. doi: 10.1038/eye.1991.46. [DOI] [PubMed] [Google Scholar]
  15. Mishima H., Masuda K., Miyake K. The putative role of prostaglandins in cystoid macular edema. Prog Clin Biol Res. 1989;312:251–264. [PubMed] [Google Scholar]
  16. Quentin C. D., Behrens-Baumann W. Doppelblindstudie über die Wirksamkeit des Prostaglandinsynthese-Hemmers Diclofenac und Dexamethasonphosphat bei der Behandlung der Iritis nach lokaler Applikation. Fortschr Ophthalmol. 1987;84(4):353–355. [PubMed] [Google Scholar]
  17. Sanders D. R., Kraff M. Steroidal and nonsteroidal anti-inflammatory agents. Effect on postsurgical inflammation and blood-aqueous humor barrier breakdown. Arch Ophthalmol. 1984 Oct;102(10):1453–1456. doi: 10.1001/archopht.1984.01040031173012. [DOI] [PubMed] [Google Scholar]
  18. Towler H. M., Cliffe A. M., Whiting P. H., Forrester J. V. Low dose cyclosporin A therapy in chronic posterior uveitis. Eye (Lond) 1989;3(Pt 3):282–287. doi: 10.1038/eye.1989.39. [DOI] [PubMed] [Google Scholar]
  19. Towler H. M., Whiting P. H., Forrester J. V. Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation. Eye (Lond) 1990;4(Pt 3):514–520. doi: 10.1038/eye.1990.68. [DOI] [PubMed] [Google Scholar]
  20. de Vries J., Baarsma G. S., Zaal M. J., Boen-Tan T. N., Rothova A., Buitenhuis H. J., Schweitzer C. M., de Keizer R. J., Kijlstra A. Cyclosporin in the treatment of severe chronic idiopathic uveitis. Br J Ophthalmol. 1990 Jun;74(6):344–349. doi: 10.1136/bjo.74.6.344. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES